Clinical trial • Phase III • Psychiatry
Clinical trial in Major Depressive Disorder | Anhedonia
Phase III trial for Major Depressive Disorder | Anhedonia. 65 participants.
Overview
- Trial Therapeutic Area
- Psychiatry
- Trial Disease
- Major Depressive Disorder | Anhedonia
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 03-12-2024
- First CTIS Authorization Date
- 14-04-2025
Trial design
Phase III trial across 1 site in Austria.
- Target Sample Size
- 65
Eligibility
Recruits 65 No vulnerable populations selected; no consent or assent handling information provided..
- Vulnerable Population
- No vulnerable populations selected; no consent or assent handling information provided.
Recruitment
- Planned Sample Size
- 65
- Recruitment Window Months
- 38
- Consent Approach
- Informed consent process not specified in the provided data; no assent information provided; languages not stated.
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 65
Austria
- Earliest CTIS Part Ii Submission Date
- 17-03-2025
- Latest Decision Or Authorization Date
- 12-04-2026
- Processing Time Days
- 391
- Number Of Sites
- 1
- Number Of Participants
- 65
Sites
- Site Name
- Medical University Of Vienna
- Department Name
- Department of Psychiatry and Psychotherapy, Division of General Psychiatry
- Contact Person Name
- Marie Spies
- Contact Person Email
- marie.spies@meduniwien.ac.at
- Number Of Participants
- 65
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Related trials
Other published trials that may interest you.